JPRN-jRCT2031230362尚未招募2 期
Phase II study of HP-6050 in patients with delirium, psychomotor agitation, and irritability
Inakura Hiroshi0 个研究点目标入组 30 人开始时间: 2023年9月25日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Japanese patients aged 18 years or older
- •- Patients with risk factors such as delirium
排除标准
- •- Patients with a serious disease that is life-threatening or requires emergency treatment
- •- Patients who cannot undergo evaluation and observation under hospitalization
- •- Patients who are not considered by the physician to require sedation with drugs
研究者
相似试验
未知
3 期
Phase 3 clinical study of DU-6859a in patients with respiratory tract infectioJPRN-jRCT2080220704DAIICHISANKYO Co.,Ltd.150
进行中（未招募）
不适用
A phase II Clinical Study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy - CP4055-201A phase II clinical study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapyEUCTR2005-000690-22-SEClavis Pharma as42
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
未知
1 期
Phase I/II study of HP-3060 in patients with allergic rhinitis.Allergic rhinitisJPRN-jRCT2080222141Hisamitsu Pharmaceutical Co., Inc.
未知
1 期
Phase 1/2 study of NS-065/NCNP-01 in patients with Duchenne muscular dystrophyDuchenne muscular dystrophyJPRN-jRCT2080223236IPPON SHINYAKU CO., LTD.16